UBS AM’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.52M Buy
141,728
+7,287
+5% +$189K ﹤0.01% 1751
2025
Q4
$3.42M Buy
134,441
+27,217
+25% +$607K ﹤0.01% 1647
2025
Q3
$1.73M Sell
107,224
-93,036
-46% -$1.51M ﹤0.01% 1816
2025
Q2
$3.2M Buy
200,260
+60,169
+43% +$910K ﹤0.01% 1930
2025
Q1
$2.39M Sell
140,091
-139,161
-50% -$2.91M ﹤0.01% 1900
2024
Q4
$6.92M Sell
279,252
-31,578
-10% -$896K ﹤0.01% 1440
2024
Q3
$8.86M Sell
310,830
-9,678
-3% -$285K ﹤0.01% 1291
2024
Q2
$8.46M Buy
320,508
+114,477
+56% +$3.26M ﹤0.01% 1213
2024
Q1
$6.66M Sell
206,031
-1,521
-0.7% -$55.5K ﹤0.01% 1144
2023
Q4
$8.74M Buy
207,552
+124,636
+150% +$4.59M ﹤0.01% 1042
2023
Q3
$3.18M Buy
82,916
+31,194
+60% +$705K ﹤0.01% 1400
2023
Q2
$802K Hold
51,722
﹤0.01% 2104
2023
Q1
$802K Buy
51,722
+7,968
+18% +$138K ﹤0.01% 2104
2022
Q4
$777K Buy
43,754
+6,409
+17% +$80.7K ﹤0.01% 1982
2022
Q3
$208K Sell
37,345
-14,597
-28% -$71.4K ﹤0.01% 2599
2022
Q2
$203K Hold
51,942
﹤0.01% 2578
2022
Q1
$286K Hold
51,942
﹤0.01% 2610
2021
Q4
$443K Hold
51,942
﹤0.01% 2601
2021
Q3
$451K Sell
51,942
-8,255
-14% -$74.5K ﹤0.01% 2537
2021
Q2
$636K Buy
60,197
+16,650
+38% +$232K ﹤0.01% 2440
2021
Q1
$698K Sell
43,547
-1,094
-2% -$28.8K ﹤0.01% 2256
2020
Q4
$2.06M Buy
44,641
+24,641
+123% +$1.14M ﹤0.01% 1672
2020
Q3
$704K Buy
20,000
+11,100
+125% +$334K ﹤0.01% 1977
2020
Q2
$217K Buy
+8,900
New +$191K ﹤0.01% 2370

Other funds holding IMVT